| Cat. No. |
Product Name / Activity |
| 2524 |
A 205804 |
| Selective inhibitor of E-selectin and ICAM-1 expression |
| 4228 |
A 286982 |
| Potent inhibitor of the LFA-1/ICAM-1 interaction |
| 1845 |
Ac2-26 |
| Annexin/lipocortin 1-mimetic; inhibits leukocyte extravasation |
| 3910 |
BIO 1211 |
| Selective α4β1 (VLA-4) inhibitor |
| 5051 |
BIO 5192 |
| Highly potent and selective inhibitor of integrin α4β1 |
| 4776 |
BIRT 377 |
| Potent negative allosteric modulator of LFA-1 |
| 6047 |
BOP |
| Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs |
| 4724 |
BTT 3033 |
| Selective inhibitor of integrin α2β1 |
| 5870 |
Cilengitide |
| Potent and selective inhibitor of integrins αvβ3 and αvβ5 |
| 3202 |
Echistatin, α1 isoform |
| Integrin αVβ3 and glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor |
| 1263 |
GR 144053 trihydrochloride |
| Glycoprotein IIb/IIIa (integrin αIIbβ3) antagonist. Antithrombotic |
| 2812 |
Heparin sodium salt |
| Anticoagulant |
| 2748 |
KF 38789 |
| Selective inhibitor of P-selectin-mediated cell adhesion |
| 4577 |
LDV FITC |
| Fluorescent ligand for α4β1 (VLA-4) |
| 6856 |
α-Mangostin |
| Modulation of cadherin expression; anticarcinogenic |
| 4664 |
Obtustatin |
| Potent and selective α1β1 inhibitor |
| 2710 |
OGT 2115 |
| Heparanase inhibitor. Antiangiogenic |
| 5760 |
P-3FAX-Neu5Ac |
| Sialic acid analog; reduces binding of E- and P-selectin |
| 3498 |
RGDS peptide |
| Integrin binding sequence; inhibits integrin receptor function |
| 4527 |
TC-I 15 |
| Potent α2β1 inhibitor; displays antithrombotic activity in vivo |
| 3900 |
TCS 2314 |
| α4β1 (VLA-4) antagonist |